申请人:Rigel Pharmaceuticals, Inc.
公开号:US08324200B2
公开(公告)日:2012-12-04
Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful.
本发明揭示了式I的化合物、含有该化合物的组合物以及使用该化合物和组合物在治疗需要调节JAK通路或抑制JAK激酶(特别是JAK2和JAK3)的情况下的方法,这些情况在治疗上具有治疗作用。